PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Award Highlights Blue Medical's Excellence in Product Differentiation - The 2010 Frost & Sullivan European Product Differentiation Excellence Award in the Medical Devices Market is presented to Blue Medical
Frost & Sullivan Award Highlights Blue Medical's Excellence in Product Differentiation

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/07/20 - The 2010 Frost & Sullivan European Product Differentiation Excellence Award in the Medical Devices Market is presented to Blue Medical.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

"The company is recognised for its contributions to enabling advances in localised drug delivery in coronary care," notes Sreevidhya Praveenkumar, Senior Research Analyst - Medical Devices at Frost & Sullivan. "Blue Medical is at the cutting-edge of a new era in medical device care that is witnessing a merging of device and pharmaceutical therapy; it's revolutionary PIONEER CoCr stent on drug eluting balloon (DEB) is a novel stent-drug combination."

The PIONEER trial, Blue Medical's clinical programme aimed at improving the quality of cardiovascular treatment, enables for the first time the delivery of a coronary stent mounted on a DEB. On placement of the stent, a predetermined load of Paclitaxel is delivered to the vessel wall to support the vessel in adapting to the stent and reducing adverse effects in the first days after implantation.

"The PIONEER CoCr Stent on DEB system pushes stent technology to the next level in cardiovascular disease management by enhancing the prognosis of the treatment and reducing disease complications and medications," states Ms Praveenkumar. This solution is in line with Blue Medical's constant efforts to meet market needs and focus on product customisation.

"Each product and technology developed by Blue Medical is designed from an end-user perspective," explains Praveenkumar. "The company's business concept of 'creative thinking' promotes cross-divisional communication to better respond to customers and incorporate their needs into creating cutting-edge technology."

The company's novel products span the range from stents, PTCA catheters and drug eluting balloons. Despite being a market with over 70 per cent saturation in terms of competitive landscape, Blue Medical has created a niche for itself in the minimally invasive cardiovascular medical device market, due to its commitment to developing innovative products.

"Blue Medical has forged a strong brand presence - its high product quality has ensured a large, loyal client pool across Europe," concludes Praveenkumar. "The major driving force behind the success of the company has been its dedicated R&D, which has resulted in unique products that have made a real, qualitative difference to patients suffering from coronary disease."

The Product Differentiation Excellence Award is awarded to the company that has excelled in the following criteria: unique features/functionality, quality/complexity, matched to target markets needs and brand perception of the uniqueness of the product.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Blue Medical

Blue Medical (bluemedical.com), located in the Dutch Brainport area, is a global medical devices company and innovator in the treatment of cardiovascular diseases. The company develops, manufactures and markets innovative medical products for cardiovascular diseases. These state-of-the-art medical devices and services offer a meaningful improvement in patient care to the health care community. The company's stents, PTCA catheters and DEB balloons are designed specially for the affordability of the cardiovascular disease population and have more than a 90 per cent acceptance in the global market.

Eefje Mertens, Marketing Manager, Blue Medical
E: eefje.mertens[.]bluemedical.com / P: +31 492 588 900

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Award Highlights Blue Medical's Excellence in Product Differentiation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | Blue Medical
Publisher Contact: Emily Bailey 
+44 (0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan
GE Healthcare Expands MRI Contrast Media Product Range in Europe with Launch of Macrocyclic Agent Clariscan
Sparta Systems Launches Product Registration Tracking for 123Compliance Cloud QMS
Frost & Sullivan Lauds SnooZeal’s Unique Electrical Stimulation Therapy for Sleep Apnea in the European Market

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)